Singh; Kaptan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Singh; Kaptan.The latest application filed is for "process for the preparation of baricitinib and an intermediate thereof".
- Singh; Kaptan - Gurgaon IN
- Singh; Kaptan - Ghaziabad IN
- Singh; Kaptan - Uttar Pradesh IN
- Singh; Kaptan - Pradesh IN
| Patent | Date |
|---|---|
| Process for the preparation of baricitinib and an intermediate thereof Grant 10,526,350 - Azad , et al. J | 2020-01-07 |
| Process For The Preparation Of Baricitinib And An Intermediate Thereof App 20190100538 - AZAD; Md Abul Kalam ; et al. | 2019-04-04 |
| Crystalline form of afatinib dimaleate Grant 10,011,591 - Singh , et al. July 3, 2 | 2018-07-03 |
| Crystalline form of baricitinib Grant 9,938,283 - Pandey , et al. April 10, 2 | 2018-04-10 |
| Process for the preparation of baricitinib and an intermediate thereof Grant 9,873,706 - Azad , et al. January 23, 2 | 2018-01-23 |
| Process For The Preparation Of Baricitinib And An Intermediate Thereof App 20170327507 - AZAD; Md Abul Kalam ; et al. | 2017-11-16 |
| Process for the preparation of 4-dimethylaminocrotonic acid Grant 9,758,471 - Verma , et al. September 12, 2 | 2017-09-12 |
| Crystalline Form Of Afatinib Dimaleate App 20170240533 - SINGH; Shravan Kumar ; et al. | 2017-08-24 |
| Crystalline Form Of Baricitinib App 20170204097 - PANDEY; Gyanendra ; et al. | 2017-07-20 |
| Amorphous Form Of Baricitinib App 20170129895 - PANDEY; Gyanendra ; et al. | 2017-05-11 |
| Process For The Preparation Of 4-dimethylaminocrotonic Acid App 20170107172 - VERMA; Shyam Sunder ; et al. | 2017-04-20 |
| Process For The Preparation Of Azilsartan Medoxomil Or Pharmaceutically Acceptable Salts Thereof App 20150011774 - Azad; Md Abul Kalam ; et al. | 2015-01-08 |
| Process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine Grant 8,748,604 - Kshirsagar , et al. June 10, 2 | 2014-06-10 |
| Process For Stereoselective Synthesis Of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine App 20130072681 - Kshirsagar; Prakash Bhimaji ; et al. | 2013-03-21 |
| Processes For The Preparation Of Form I And Form Ii Of Palonosetron Hydrochloride App 20120267533 - Pandey; Gyanendra ; et al. | 2012-10-25 |
| Process For The Preparation Of Fosamprenavir Calcium App 20120220786 - Bhoge; Satish Manohar ; et al. | 2012-08-30 |
| Crystalline Form Of Fosamprenavir Calcium App 20120208787 - Bhoge; Satish Manohar ; et al. | 2012-08-16 |
| Amorphous Fosamprenavir Calcium App 20120135965 - Bhoge; Satish Manohar ; et al. | 2012-05-31 |
| Crystalline Forms Of Atorvastatin Magnesium App 20090306173 - TYAGI; Vipin ; et al. | 2009-12-10 |
| Enantiomerically pure cilazapril, process for preparation App 20060293517 - Kumar; Yatendra ; et al. | 2006-12-28 |
| Process for the preparation of acitretin Grant 7,129,365 - Kumar , et al. October 31, 2 | 2006-10-31 |
| Cefpodixime proxetil Grant 7,045,618 - Kumar , et al. May 16, 2 | 2006-05-16 |
| Process for the preparation of acitretin App 20040192949 - Kumar, Yatendra ; et al. | 2004-09-30 |
| Cefpodixime proxetil App 20040092734 - Kumar, Yatendra ; et al. | 2004-05-13 |
| Amorphous form of cefpodoxime proxetil Grant 6,602,999 - Kumar , et al. August 5, 2 | 2003-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 